Clinical Trials in San Antonio

Showing 3661-3680 of 7,028 trials

A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis

NCT04271514

This study is a first-in-human, 3-part, multi-center, Phase 1, randomized, double-blind, placebo-controlled study with RPT193 in up to 64 healthy male and female subjects and 30 male and female patients with atopic dermatitis. RPT193 is an orally-available, potent, and selective antagonist of CCR4.

Atopic Dermatitis

RAPT Therapeutics, Inc.103 participantsStarted Aug 2019

Anniston, Alabama, United States • Scottsdale, Arizona, United States • San Diego, California, United States +11 more locations

COMPLETEDPhase 2< 1 mile

Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy

NCT03664921

This study evaluates the analgesic effect of Omnitram for the treatment of painful diabetic neuropathy. Each subject with diabetic neuropathy will be treated for four weeks with Omnitram and for four weeks with placebo. The order of the Omnitram and placebo treatment will be random.

Diabetic NeuropathiesNeuropathic PainPain, Chronic

Syntrix Biosystems, Inc.55 participantsStarted Nov 2018

Anaheim, California, United States • Cerritos, California, United States • St Louis, Missouri, United States +1 more locations

A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis

Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy

Find Trials by Condition in San Antonio

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)

A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Study of ADG116 in Patients With Advanced/Metastatic Solid Tumors

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

Core Study of the Safety and Effectiveness of IDEAL IMPLANT(R) Saline-filled Breast Implants

Neoadjuvant GW572016 to Treat Breast Cancer

Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady)

Assessing Symptomatic Clinical Episodes in Depression

Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma